The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
Making the Energy Efficiency Case to the C-Suite
How to Avoid HAIs This Flu Season
Design Phase Set to Begin for Hospital Annex at SUNY Upstate Medical
Building Hospital Resilience in an Era of Extreme Weather
Ennoble Care Falls Victim to Data Breach